H

H1

469 employees

H1 provides a health data platform to support the end-to-end therapeutic development process of medical companies and healthcare systems.

Basic info

Industry

software development

Sectors

Biotechnology
pharmaceutical
biotechnology
healthcare content
msl
kol
healthcare
Data Science
key opinion leaders
data science
global drug development
diversity data
Medical Affairs
clinical trials
life sciences
medical device
medical science liaison
clinical operations
Healthcare content
msl education
SaaS
AI
kol mapping
medical affairs
healthcare professional information
Pharmacuticals
provider data
healthcare data
Health Care
Therapeutics
medtech sales
Healthcare
Medical
Life Science
HCPs

Date founded

2017

Funding rounds raised

Total raised

$100M

from 26 investors over 26 rounds

H

H1 raised $23M on June 9, 2022

Investors: Novartis Japan, Goldman Sachs Asset Management, Menlo Ventures and Leerink Transformation Partners

H

H1 raised $100M on November 16, 2021

Investors: Altimeter, Lux Capital, IVP, Menlo Ventures, Flex Capital, dRx data, Lead Edge Capital, Goldman Sachs Asset Management and Leerink Transformation Partners

H

H1 raised $58M on December 17, 2020

Investors: Y Combinator, Leerink Transformation Partners, IVP, Lead Edge Capital, dRx data, Lux Capital and Menlo Ventures

H

H1 raised $13M on March 22, 2020

Investors: ClearPoint Investment Partners, Liquid 2 Ventures, Y Combinator, dRx data and Menlo Ventures

H

H1 raised undisclosed on January 30, 2020

Investors: Y Combinator

FAQ